The phenotypic characteristics of pre-existing SARS-CoV-2-reactive T cells may be consistent with the observation that seroconversion for anti-SARS-CoV-2 IgM and IgG occurs simultaneously in some COVID-19 patients (Long et al., 2020). This evidence concerns the gene CD40LG and COVID-19.